GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Cyclically Adjusted PB Ratio

Ajanta Pharma (BOM:532331) Cyclically Adjusted PB Ratio : 10.77 (As of May. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Ajanta Pharma's current share price is ₹2419.00. Ajanta Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹224.58. Ajanta Pharma's Cyclically Adjusted PB Ratio for today is 10.77.

The historical rank and industry rank for Ajanta Pharma's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:532331' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.76   Med: 8.17   Max: 10.78
Current: 10.78

During the past years, Ajanta Pharma's highest Cyclically Adjusted PB Ratio was 10.78. The lowest was 6.76. And the median was 8.17.

BOM:532331's Cyclically Adjusted PB Ratio is ranked worse than
94.66% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs BOM:532331: 10.78

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ajanta Pharma's adjusted book value per share data for the three months ended in Mar. 2024 was ₹283.313. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹224.58 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ajanta Pharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ajanta Pharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Cyclically Adjusted PB Ratio Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.76 9.97

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.76 - 8.85 - 9.97

Competitive Comparison of Ajanta Pharma's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Cyclically Adjusted PB Ratio falls into.



Ajanta Pharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ajanta Pharma's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2419.00/224.58
=10.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ajanta Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ajanta Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=283.313/153.0345*153.0345
=283.313

Current CPI (Mar. 2024) = 153.0345.

Ajanta Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.000 94.103 0.000
201409 0.000 96.780 0.000
201412 0.000 96.780 0.000
201503 68.562 97.163 107.987
201506 0.000 99.841 0.000
201509 77.959 101.753 117.248
201512 0.000 102.901 0.000
201603 90.215 102.518 134.669
201606 0.000 105.961 0.000
201609 109.202 105.961 157.715
201612 0.000 105.196 0.000
201703 118.757 105.196 172.762
201706 0.000 107.109 0.000
201709 136.220 109.021 191.213
201712 0.000 109.404 0.000
201803 154.623 109.786 215.534
201806 0.000 111.317 0.000
201809 171.913 115.142 228.489
201812 0.000 115.142 0.000
201903 171.546 118.202 222.098
201906 0.000 120.880 0.000
201909 188.797 123.175 234.564
201912 0.000 126.235 0.000
202003 198.551 124.705 243.656
202006 0.000 127.000 0.000
202009 222.571 130.118 261.771
202012 0.000 130.889 0.000
202103 230.792 131.771 268.035
202106 0.000 134.084 0.000
202109 258.767 135.847 291.506
202112 0.000 138.161 0.000
202203 254.781 138.822 280.866
202206 0.000 142.347 0.000
202209 281.247 144.661 297.526
202212 0.000 145.763 0.000
202303 267.443 146.865 278.678
202306 0.000 150.280 0.000
202309 276.523 151.492 279.339
202312 0.000 152.924 0.000
202403 283.313 153.035 283.313

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ajanta Pharma  (BOM:532331) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ajanta Pharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajanta Pharma (BOM:532331) Business Description

Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines